Recent news on Adagen

Enzon Stockholders Approve Company Proposals at 2007 Annual Meeting  -  May 16, 2007
PharmaLive.com (press release),Enzon's PEGylation technology was used to develop two of its products, Oncaspar and Adagen, and has created a royalty revenue stream from licensing

Enzon Announces Timing of Annual Meeting of Shareholders  -  Apr 24, 2007
Business Wire (press release),Enzon’s PEGylation technology was used to develop two of its products, Oncaspar and Adagen, and has created a royalty revenue stream from licensing

FDA Grants Full Approval for DepoCyt for the Treatment of ...  -  Apr 20, 2007
PharmaLive.com (press release),Enzon's PEGylation technology was used to develop two of its products, Oncaspar and Adagen, and has created a royalty revenue stream from licensing

Enzon's PEG-SN38 Shows Anti-Tumor Activity in Resistant ...  -  Apr 18, 2007
PipelineReview.com (press release),Currently, there are five marketed biologic products that utilize our proprietary PEG platform, two of which Enzon markets, Adagen(R) and Oncaspar(R),

Enzon Enrolls First Patient in Phase 1 Study of Its HIF-1 Alpha ...  -  Mar 29, 2007
PipelineReview.com (press release),Enzon's specialized sales force markets Abelcet(R), Oncaspar(R), Adagen(R), and DepoCyt(R) in the United States. In addition, Enzon also receives royalties

Enzon Enrolls First Patient in Phase 1 Study of Its HIF-1 Alpha ...  -  Mar 29, 2007
Business Wire (press release),Enzon's specialized sales force markets Abelcet®, Oncaspar®, Adagen®, and DepoCyt® in the United States. In addition, Enzon also receives royalties on sales

Enzon to Present at Cowen 27th Annual Health Care Conference  -  Mar 6, 2007
Business Wire (press release),Enzon’s specialized sales force markets Abelcet ® , Oncaspar ® , Adagen ® , and Depocyt ® in the United States. In addition, Enzon also receives royalties

Enzon to Present at Cowen 27th Annual Health Care Conference  -  Mar 6, 2007
PharmaLive.com (press release),Enzon's specialized sales force markets Abelcet(R), Oncaspar(R), Adagen(R), and Depocyt(R) in the United States. In addition, Enzon also receives royalties

Enzon Reports 2006 Financial Results and Accomplishments  -  Feb 13, 2007
Genetic Engineering News (press release),Sales of Adagen, an enzyme replacement therapy used to treat adenosine deaminase (ADA) deficiency in patients with severe combined immuno-deficiency disease

Enzon Announces Consolidation of Its Manufacturing Operations in ...  -  Feb 4, 2007
dBusinessNews Newark (press release),Enzon’s specialized sales force markets Abelcet®, Oncaspar®, Adagen®, and Depocyt ® in the United States. In addition, Enzon also receives royalties on

Enzon Announces Consolidation of Its Manufacturing Operations in ...  -  Feb 2, 2007
Business Wire (press release),Enzon’s specialized sales force markets Abelcet ® , Oncaspar ® , Adagen ® , and Depocyt ® in the United States. In addition, Enzon also receives royalties

Enzon Announces Consolidation of Its Manufacturing Operations in ...  -  Feb 2, 2007
Genetic Engineering News (press release),Enzon's specialized sales force markets Abelcet(R), Oncaspar(R), Adagen(R), and Depocyt (R) in the United States. In addition, Enzon also receives royalties

Enzon Announces CEO Cancer Gold Standard Accreditation  -  Jan 10, 2007
American Digital Networks (press release),Enzon's specialized sales force markets Abelcet(R), Oncaspar(R), Adagen(R), and Depocyt (R) in the United States. In addition, Enzon also receives royalties

Enzon Announces CEO Cancer Gold Standard Accreditation  -  Jan 10, 2007
Business New Jersey (subscription),Enzon’s specialized sales force markets Abelcet®, Oncaspar®, Adagen®, and Depocyt ® in the United States. In addition, Enzon also receives royalties on

Enzon Announces CEO Cancer Gold Standard Accreditation  -  Jan 10, 2007
Business Wire (press release),Enzon’s specialized sales force markets Abelcet ® , Oncaspar ® , Adagen ® , and Depocyt ® in the United States. In addition, Enzon also receives royalties

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional